Hormone receptors in breast cancer and response to chemotherapy.

M. E. Lippman; J. C. Allegra

Hormone receptors in breast cancer and response to chemotherapy.

M. E. Lippman, J. C. Allegra

Medicine

Research output: Contribution to journal › Letter › peer-review

Abstract

Other data reveal the important prognostic value of estrogen-receptor determinations in identifying patients at greater risk of relapse. The data of Drs. Legha et al. do not allow any conclusions on the effect of receptor status, as assessed (indirectly) by previous hormone responsiveness on response to chemotherapy. Dr. Panko has identified important potential problems with the study of Kiang et al. There is no question that some estrogen-receptor tumors can on substquent biopsies be estrogen-receptor positive; chemotherapy may enhance this selection of cells.

Original language	English (US)
Number of pages	1
Journal	New England Journal of Medicine
Volume	300
Issue number	18
State	Published - May 3 1979

ASJC Scopus subject areas

Medicine(all)

UN SDGs

This output contributes to the following Sustainable Development Goal(s)

Fingerprint Dive into the research topics of 'Hormone receptors in breast cancer and response to chemotherapy.'. Together they form a unique fingerprint.

Cite this

@article{775034d5acb54a3a99937935349994ea,

title = "Hormone receptors in breast cancer and response to chemotherapy.",

abstract = "Other data reveal the important prognostic value of estrogen-receptor determinations in identifying patients at greater risk of relapse. The data of Drs. Legha et al. do not allow any conclusions on the effect of receptor status, as assessed (indirectly) by previous hormone responsiveness on response to chemotherapy. Dr. Panko has identified important potential problems with the study of Kiang et al. There is no question that some estrogen-receptor tumors can on substquent biopsies be estrogen-receptor positive; chemotherapy may enhance this selection of cells.",

author = "Lippman, {M. E.} and Allegra, {J. C.}",

year = "1979",

month = may,

day = "3",

language = "English (US)",

volume = "300",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "18",

}

TY - JOUR

T1 - Hormone receptors in breast cancer and response to chemotherapy.

AU - Lippman, M. E.

AU - Allegra, J. C.

PY - 1979/5/3

Y1 - 1979/5/3

N2 - Other data reveal the important prognostic value of estrogen-receptor determinations in identifying patients at greater risk of relapse. The data of Drs. Legha et al. do not allow any conclusions on the effect of receptor status, as assessed (indirectly) by previous hormone responsiveness on response to chemotherapy. Dr. Panko has identified important potential problems with the study of Kiang et al. There is no question that some estrogen-receptor tumors can on substquent biopsies be estrogen-receptor positive; chemotherapy may enhance this selection of cells.

AB - Other data reveal the important prognostic value of estrogen-receptor determinations in identifying patients at greater risk of relapse. The data of Drs. Legha et al. do not allow any conclusions on the effect of receptor status, as assessed (indirectly) by previous hormone responsiveness on response to chemotherapy. Dr. Panko has identified important potential problems with the study of Kiang et al. There is no question that some estrogen-receptor tumors can on substquent biopsies be estrogen-receptor positive; chemotherapy may enhance this selection of cells.

UR - http://www.scopus.com/inward/record.url?scp=0018780665&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018780665&partnerID=8YFLogxK

M3 - Letter

C2 - 431604

AN - SCOPUS:0018780665

VL - 300

JO - New England Journal of Medicine

JF - New England Journal of Medicine

SN - 0028-4793

IS - 18

ER -

Hormone receptors in breast cancer and response to chemotherapy.

Abstract

ASJC Scopus subject areas

UN SDGs

Other files and links

Cite this